Importantly, these atomic structures could be utilized to screen and identify therapeutic candidates that might modify the stability of these structures and thus alter the C9-NRE-linked ALS/FTD disease cascade in patients. This evidence concerns the gene C9 and amyotrophic lateral sclerosis.